跳至主要内容
临床试验/NCT07735741
NCT07735741尚未招募不适用

Immune Dysregulation During Sepsis: A Natural History Cohort

National Heart, Lung, and Blood Institute (NHLBI)1 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2027年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
500
试验地点
1
主要终点
To investigate the contribution of neutrophils and neutrophil subsets including low density neutrophils to the dysregulated immune response that occurs during the acute phase of sepsis.

研究概览

简要总结

Background:

Sepsis is an illness that occurs when the body s immune system runs out of control. This can damage organs. Sepsis causes an estimated 1 in 5 deaths worldwide. In this natural history study, researchers want to learn more about how the immune system changes during sepsis. They hope this knowledge will help them find better ways to treat sepsis.

Objective:

To understand how sepsis affects the body over time.

Eligibility

People aged 18 years and older admitted to INOVA Fairfax Hospital in Virginia and who have sepsis.

Design:

Researchers will collect data from participants medical records.

Participants will have blood drawn at least 5 times while they are in the hospital. Blood may be collected for up to 30 days, if they remain in the hospital that long. The blood will be taken from access lines that are already in place. Some blood draws will be optional.

Participants may opt to have up to 3 tests of their heart function while they are in the hospital.

Some participants may have a sample of fluid collected from their lungs.

Participants will have a follow-up visit about 90 days after they join the study. This visit will be by phone call if they have left the hospital. They will fill out a questionnaire. They will answer questions about their health and how they feel. The call will last about 30 minutes....

详细描述

Study Description:

This is a natural history study intended to allow the characterization of neutrophil biology and other contributors to the pathogenesis along with short-term outcomes of patients hospitalized with sepsis. Patients admitted to INOVA Fairfax Hospital with sepsis will be enrolled, undergo clinical evaluation, clinical data capture, and will have blood drawn that will be processed and analyzed at the NIH.

Objectives:

The aim of this natural history/observational study is to develop a cohort of patients admitted to the hospital with sepsis who can be followed longitudinally to achieve the following:

Primary objectives:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • INCLUSION CRITERIA:
  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Age >= 18 years old
  • Admitted to INOVA Fairfax Hospital
  • Meets sepsis-3 definition of sepsis in the last 48 hours
  • Suspected infection
  • Evidence of organ dysfunction (SOFA score >= 2)
  • Ability of subject or LAR to understand and the willingness to sign a written informed consent document

排除标准

  • Any individual who meets any of the following criteria will be excluded from participation in this study:
  • Hemoglobin < 7 microgram/dL at the time of enrollment
  • Hemoglobin <10 microgram/dL in patients with known coronary artery disease or active EKG changes consistent with acute ischemia
  • Currently receiving infusion of epinephrine; or dopamine at an infusion rate of > 2.5
  • microgram/kg/min, norepinephrine of > 20 mircogram/min, or vasopressin > 0.04 units/min
  • Neutropenia (absolute neutrophil count less than 1000 cells/microliter)
  • Baseline cognitive impairment
  • Pregnancy

结局指标

主要结局

To investigate the contribution of neutrophils and neutrophil subsets including low density neutrophils to the dysregulated immune response that occurs during the acute phase of sepsis.

时间窗: 10 years

The primary outcomes is intended to study how certain immune cells contribute to sepsis pathogenesis.

次要结局

  • To characterize spleen tyrosine kinase expression across immune cells and correlate with soluble biomarkers, cellular phenotypes and gene expression to determine mechanistic pathways that may be amenable to host-direct therapies.(10 years)

研究者

申办方类型
Nih
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验